204 related articles for article (PubMed ID: 4570933)
1. The spectrum of myeloproliferative disorders.
Gilbert HS
Med Clin North Am; 1973 Mar; 57(2):355-93. PubMed ID: 4570933
[No Abstract] [Full Text] [Related]
2. The myeloproliferative disorders.
Gilbert HS; Dameshek W
Dis Mon; 1970 Oct; ():1-52. PubMed ID: 4921953
[No Abstract] [Full Text] [Related]
3. [MYELOPROLIFERATIVE DISORDERS].
MARCIACQ ALTAFULLA
Arch Med Panamenos; 1963 Aug; 12():149-59. PubMed ID: 14164997
[No Abstract] [Full Text] [Related]
4. [THE PLACE OF OSTEOMYELOSCLEROSIS AMONG THE MYELOPROLIFERATIVE DISEASES].
STOBBE H
Dtsch Gesundheitsw; 1965 Jan; 20():13-20. PubMed ID: 14265017
[No Abstract] [Full Text] [Related]
5. [MYELOPROLIFERATIVE SYNDROMES].
PIRESWDA F
Folha Med; 1964 Apr; 48():195-201. PubMed ID: 14271209
[No Abstract] [Full Text] [Related]
6. [Primary and secondary thrombocythemia: apropos of 39 cases].
Bernadou A; Loo H; Prost RJ; Doumenc J; Zittoun R; Bilski-Pasquier G
Sem Hop; 1968 Jun; 44(31):2092-100. PubMed ID: 4300454
[No Abstract] [Full Text] [Related]
7. [HEMORRHAGIC THROMBOCYTHEMIA AND THE "MYELOPROLIFERATIVE SYNDROME"].
VON KNORRING
Nord Med; 1964 Dec; 72():1443-6. PubMed ID: 14211013
[No Abstract] [Full Text] [Related]
8. Myeloproliferative disorders.
Young KM
Vet Clin North Am Small Anim Pract; 1985 Jul; 15(4):769-81. PubMed ID: 3898534
[TBL] [Abstract][Full Text] [Related]
9. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
10. Experimental and clinical megakaryocytopoiesis.
Ebbe S
Clin Haematol; 1979 Jun; 8(2):371-94. PubMed ID: 158454
[No Abstract] [Full Text] [Related]
11. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
12. Myeloproliferative disorders in dogs and cats.
Harvey JW
Vet Clin North Am Small Anim Pract; 1981 May; 11(2):349-81. PubMed ID: 7032050
[No Abstract] [Full Text] [Related]
13. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
Tangün Y
Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
[No Abstract] [Full Text] [Related]
14. Beta-thromboglobulin content in megakaryocytes of patients with myeloproliferative diseases.
Grossi A; Vannucchi AM; Rafanelli D; Filimberti E; Rossi Ferrini P
Thromb Res; 1986 Aug; 43(3):367-74. PubMed ID: 2426823
[No Abstract] [Full Text] [Related]
15. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders.
Martyré MC
Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621
[TBL] [Abstract][Full Text] [Related]
16. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
Campr V
Cesk Patol; 2011 Jul; 47(3):84-93. PubMed ID: 21887923
[TBL] [Abstract][Full Text] [Related]
17. The platelet-cancer loop in myeloproliferative cancer. Is thrombocythemia an enhancer of cancer invasiveness and metastasis in essential thrombocythemia, polycythemia vera and myelofibrosis?
Hasselbalch HC
Leuk Res; 2014 Oct; 38(10):1230-6. PubMed ID: 25149709
[TBL] [Abstract][Full Text] [Related]
18. Myeloproliferative syndromes: diagnosis and therapeutic options.
Hellmann A
Pol Arch Med Wewn; 2008 Dec; 118(12):756-60. PubMed ID: 19202955
[TBL] [Abstract][Full Text] [Related]
19. Transitions among the myeloproliferative disorders.
Glasser RM; Walker RI
Ann Intern Med; 1969 Aug; 71(2):285-307. PubMed ID: 5257058
[No Abstract] [Full Text] [Related]
20. [Myeloproliferative disorders].
Binder D; Fehr J
Ther Umsch; 2004 Feb; 61(2):131-42. PubMed ID: 15018396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
